Total Funding
32
27
Total FundingSeed raised
Growth Score
-1 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
129077
FineImmu develops solid tumor immunotherapy drugs.
About the Company
FineImmu produces cell therapy drugs and immunodiagnostic products. The drug predicts the anti-tumor immune function of PD-1 and PD-L1 and the therapeutic effect of immune checkpoint inhibitors such as CTLA4. The company's contact modes are by phone and physical address.
